|
|
|
|
HerceptinGlasgow Daily Record, ...recognition award. The mum fought against her local health bosses last year to be able to receive the breast cancer drug herceptin. Her ... Deutsche Bank Raises Roche Target To CHF240 16 Jan 2006 New Ratings ..."With investors seemingly focused on how big Avastin and Herceptin can become and 'panic' buying of Tamiflu ahead of a potential 'flu pandemic, Roche's biggest ... Campaign wins honour for 'Flood Woman' 16 Jan 2006 Yorkshire Post Today, The mother of two from Somerset, fought against her Primary Care Trust last year to be able to receive the breast cancer drug Herceptin. ... Response humbles cancer sufferer 16 Jan 2006 Wairarapa Times Age, The drug Herceptin has been developed by Swiss drug company Roche to deal with cases like Raewyn's – an estimated 200 in New Zealand at present – but it is ... Researchers Discover Protein Fragment That Helps Predict Breast ... 16 Jan 2006 Science Daily (press release) ...to determine if the presence of p95 has any significance regarding responsiveness of the cancers to chemotherapy, anti-estrogen therapy or Herceptin [a drug ... breast cancer drug for county patients Jan 14, 2006 Wrexham Evening Leader, North East Wales Trust is one of two regional health providers to agree in principle the use of Herceptin for certain patients. ... Herceptin may work better when it is followed by injections of ... Jan 5, 2006 News-Medical.net, This new study is the first to indicate that the drug trastuzumab, also known as Herceptin, may work better when it is followed by injections of interleukin (IL ... Herceptin plus chemotherapy improves disease-free survival in ... Jan 7, 2006 Xagena.it, The therapy Herceptin with chemotherapy in patients with early stage breast cancer significantly increases disease-free survival time in women who test ... Woman wins right to bring Herceptin challenge Dec 21, 2005 Times Online, ...diagnosed with an aggressive form of breast cancer has been told she can mount a legal challenge to her NHS trust’s refusal to give her the drug Herceptin. ... Judge orders health trust to fund interim course of Herceptin for ... Dec 21, 2005 The Observer, A high court judge yesterday ordered NHS managers to pay for a woman with breast cancer to have the unlicensed drug Herceptin until her legal challenge to ... Patient wins Herceptin review Dec 21, 2005 The Observer, The NHS came under further pressure to increase the availability of the breast cancer drug Herceptin today after a woman won the right to a judicial review of ... NCCN Includes Herceptin® in Guidelines as Therapy in HER2 ... Dec 21, 2005 Cancer Consultants (press release), The National Comprehensive Cancer Network (NCCN) has recently added HER2 testing and the use of the targeted agent Herceptin® to their guidelines for ... Women taking trust to court over Herceptin Dec 21, 2005 DeHavilland, A woman refused the breast cancer drug Herceptin by her local NHS trust has won the right to take her case to the high court. Swindon ... Herceptin, new breast cancer medication Dec 20, 2005 Auburn Citizen, Recently, through my digging I have found a new breast cancer medication, Herceptin. Herceptin is the only FDA-approved therapy ... Addition of Herceptin® to Adjuvant Chemotherapy Improves Breast ... Dec 13, 2005 Cancer Consultants (press release), Interim results from the HERA (Herceptin Adjuvant) Trial indicate that the addition of Herceptin (trastuzumab) to adjuvant chemotherapy for early breast cancer ... C-myc Gene Influences Response to Herceptin® Dec 14, 2005 Cancer Consultants (press release), ...gene in addition to amplification of the HER2 gene have a lower risk of recurrence and death after treatment with chemotherapy and Herceptin® than patients ... Interim Analysis on HERA Trial: Herceptin in Adjuvant Breast ... Dec 14, 2005 Cancer Consultants (press release), Researchers affiliated with the HERA Study Team reported interim results indicating that the addition of Herceptin to adjuvant chemotherapy improves disease ... Non-Anthracycline Chemotherapy Regimen Plus Herceptin®: Effective ... Dec 13, 2005 Cancer Consultants (press release), ...appears to provide the same benefit as anthracycline-containing regimens, without the heart complications, when used with Herceptin (trastuzumab) for the ... cMyc Amplification Confers Increased Activity with the Addition of ... Dec 13, 2005 Cancer Consultants (press release), ...patients with amplified HER2 plus amplified cMyc have a significantly reduced risk of recurrence and death with the addition of Herceptin to chemotherapy when ... Cancer patients plead to make drug cheap Jan 11, 2006 Melbourne Herald Sun, BREAST cancer patients have called on drug company Roche to speed up a process to make breast cancer drug Herceptin cheaper. Law ... Genentech Announces Full Year and Fourth Quarter 2005 Results Jan 10, 2006 MSN Money US sales of Herceptin(R) (Trastuzumab) in 2005 increased 56 percent to $747.2 million from $479.0 million in 2004. Fourth quarter ... Genentech Says 4th-Qtr Profit Climbs on Cancer Drug Sales Jan 10, 2006 Bloomberg Inc., the world's second- biggest biotechnology company, said quarterly profit jumped as more doctors prescribed the Avastin and Herceptin cancer drugs. ... 'My mother was sat beside me and I remember thinking 'If she's ... Jan 7, 2006 The Observer, But thanks to Herceptin, breast cancer sufferers could now look forward to a long life. ... And Genentechhad also registered a trade name for it: Herceptin. ... Genentech's 4th-Qtr Profit Climbs 64% on Cancer Drugs (Update2) Jan 10, 2006 Bloomberg Genentech is counting on Avastin and the Herceptin breast- cancer treatment to help the company pass Amgen Inc. ... The company introduced Herceptin in 1998. ... Your money or your life for cancer sufferers Jan 6, 2006 New Zealand Herald, She wants Herceptin treatment for breast cancer and her oncologist has told her she is an ideal candidate but that it would cost $100,000. ... No WAG cash for cancer drugs Jan 11, 2006 ic Wales, First Minister Rhodri Morgan yesterday admitted that "no special thought" had been given to the issue of how to pay for drugs such as Herceptin, if it is ... More Upside Expected From Genentech Jan 10, 2006 TheStreet.com 10. In the fourth quarter, Genentech will continue to enjoy easy year-over-year comparisons and outsized gains in its Avastin and Herceptin product lines. ... Genentech up 64% in quarter after good year on many fronts Jan 10, 2006 San Francisco Chronicle, For the full year, Genentech's revenue reached a record $6.6 billion, fed by the sustained growth of its mainstay cancer drugs Rituxan, Herceptin and Avastin. ... Genentech income rises 64% in quarter Jan 11, 2006 San Jose Mercury News, ...with the successful launch of Avastin and its future potential.'' Avastin is one of Genentech's three main anti-cancer drugs, along with Herceptin and Rituxan. ... Genentech Announces Full Year and Fourth Quarter 2005 Results Jan 10, 2006 Yahoo! News (press release) US sales of Herceptin® (Trastuzumab) in 2005 increased 56 percent to $747.2 million from $479.0 million in 2004. Fourth quarter ... Genentech: An expensive darling Jan 9, 2006 CNN/Money ..."Herceptin sales are ramping up very quickly over the last few months and I think that's where you'll see most of the upside in the fourth quarter.". ... Breast Cancer Drug Should Be Made Widely Available Jan 9, 2006 MedIndia, Debra Orr, a Canadian woman who has survived breast cancer twice, says that all women deserve access to the new drug Herceptin. ... Cancer patients plead to make drug cheaper (Herald Sun) Jan 11, 2006 AustralianDoctor.com (subscription), Breast cancer patients have called on drug company Roche to speed up a process which could cut the cost of breast cancer drug Herceptin, the Herald Sun reported ... Nurse wins fight for cancer drug Jan 9, 2006 Chichester Today, Chris McKrill has received the go-ahead from them to be treated with Herceptin. She will undergo her first intravenous session of the drug in five weeks. ... Fish and drips Jan 4, 2006 Guardian Unlimited, ...the same time as Matt, the healthcare-at-home nurse, who comes round every third Tuesday these days to hook me up to a plastic bag that drips Herceptin into my ... UPDATE 1-Cancer drug sales lift Genentech quarterly profit Jan 10, 2006 Reuters Profile, Research) on Tuesday reported that fourth-quarter profit rose 64 percent on continued surging sales of its breast cancer drug Herceptin and other ... Cancer drug sales lift Genentech quarterly profit Jan 10, 2006 Reuters ...vice president of commercial operations, said that while there has been considerable interest from doctors in prescribing breast cancer drug Herceptin for not ... Cancer drug sales lift Genentech quarterly profit Jan 10, 2006 Reuters ...vice president of commercial operations, said that there has been considerable interest from doctors in prescribing breast cancer drug Herceptin for not yet ... Genentech's Earnings Skyrocket 64% Jan 11, 2006 Los Angeles Times, ...president of commercial operations, said that although there had been considerable interest from doctors in prescribing breast cancer drug Herceptin for off ... Cancer drug praised Jan 9, 2006 Calgary Sun, ...breast cancer. As it stands, there are disparities from province to province on whether the drug, Herceptin, is funded. Alberta ... DRUG FIGHT FOR BREAST CANCER MAN Jan 11, 2006 Mirror.co.uk, A MALE breast cancer sufferer has vowed to fight for the right to have wonder drug Herceptin. Stuart Waver, in remission after chemotherapy ... Immune-system boosters aid cancer drugs Jan 9, 2006 United Press International So says a new study from Ohio State University that found that the cancer drug Herceptin (trastuzumab) may be even more effective in fighting breast cancer ... New Report Reveals Trends in Cancer Treatment and Emerging ... Jan 11, 2006 Yahoo! News (press release) Biologic therapies such as Genentech's Avastin and Herceptin have altered the treatment landscape and other new targeted therapies will no doubt shape clinical ... Kylie finishes 'successful' breast cancer treatment Jan 13, 2006 Times Online, Every report, however, suggests that she has had the very latest treatment and many of those reports have suggested she has had herceptin. ... Best Oncology Pipeline: Roche Jan 10, 2006 R&D Directions (subscription), Roche’s oncology business includes five products proven to provide survival benefit in different major tumor indications: Avastin, Herceptin, and Xeloda in ... Genentech's Product Mix Could Boost Margins In 2006 Jan 11, 2006 Forbes Genentech reported better-than-expected sales results for Avastin, its colorectal cancer treatment, as well as for Herceptin for breast cancer, and Rituxan for ... HSE ‘pressure’ on hospital to withhold cancer drugs Dec 31, 2005 The Sunday Times, Correspondence from last autumn, obtained under the Freedom of Information Act, reveals that the hospital wants more money for Herceptin and Avastin, top-end ... Roche "buy" Jan 11, 2006 New Ratings The sales of Roche's Herceptin drug for the treatment of breast cancer are likely to have been ahead of expectations, the analysts say. ... Genentech "neutral," target price raised Jan 11, 2006 New Ratings Genentech has posted higher-than-expected sales of its Herceptin and Rituxan drugs, while Avastin’s sales were short of the consensus, the analysts say. ... Immune stimulants may help cancer patients, study shows Jan 9, 2006 Pharmaceutical Business Review 6 Jan 2006, 16:29 GMT - This investigation is the first to indicate that the drug trastuzumab (marketed by Genentech as Herceptin) may work better when it is ... Roche Investors Keep Eye On Genentech 4Q Jan 10, 2006 New Ratings ..."The focus of attention will once again be on the extent of off-label use with Avastin in lung cancer and of Herceptin in adjuvant breast cancer," says Lombard ... Morgan Stanley Sees Roche Beating The Street Jan 10, 2006 New Ratings Very strong Tamiflu sales and considerable off-label Herceptin use, especially outside of US, means product mix is better says the bank. ... Alberta cancer victims get breakthrough drug Jan 6, 2006 Edmonton Journal, Alberta women fighting breast cancer have received the breakthrough drug Herceptin thanks to the fund-raising efforts of thousands of Calgarians last summer. ... Earnings Outlook Genentech earnings to roll next week Jan 6, 2006 MarketWatch Piper Jaffray expects the focus of the earnings release and the subsequent conference call to be on the company's 2006 outlook, along with Herceptin and Avastin ... Pitt sees new role for cancer drug Dec 26, 2005 Pittsburgh Post Gazette, By Joe Fahy, Pittsburgh Post-Gazette. The drug Herceptin may help battle an aggressive form of breast cancer by righting a cell pathway gone wrong. ... Interim Analysis of Phase 3 Study Shows Taxotere (docetaxel)-Based ... Dec 16, 2005 DG News ...the results from the first interim efficacy and updated safety analyses from the BCIRG 006 phase 3 breast cancer study, which show that Herceptin(R) combined ... Bureaucracy blamed for cancer drug delays Jan 6, 2006 ic Wales, ...awaiting approval. They include the use of Herceptin for early-stage breast cancer and Cetuximab for bowel cancer. Although many ... Genentech Falls 4% on Avastin Jan 11, 2006 Red Herring, ...“We believe that the shortfall versus our expectations was likely due to slower-than-expected uptake of Avastin and Herceptin in these areas,� wrote ... PDL Shares Slip on Genentech Results Jan 11, 2006 MSN Money PDL also receives payments on Genentech's Herceptin, a breast cancer therapy, its Xolair asthma drug and the Raptiva psoriasis treatment. ... Breast cancer discovery is year's 'biggest news' Dec 26, 2005 USA Today ...this year, experts say, was the news that certain patients with early-stage breast cancer can cut their risk of relapse in half by taking the drug Herceptin. ... PETA Pans Breakthrough in Breast Cancer Treatment Dec 30, 2005 The Heartland Institute, Studies published in the October 20, 2005 edition of the New England Journal of Medicine indicate Herceptin, a drug already shown to prolong survival in ... Plea to have cancer drug Dec 23, 2005 Shropshire Star, Revolutionary breast cancer drug Herceptin could be offered on the NHS to women from Shropshire and Mid Wales currently battling the disease, it was revealed ... New drug combo may boost cancer treatment Jan 6, 2006 Monsters and Critics.com, 1 issue of the journal Cancer Research, is the first to indicate that the drug trastuzumab -- also known as Herceptin -- may work better when it is followed by ... NHS: Condition critical Jan 5, 2006 Socialist Party, ...treatment? What choice for the patient refused the breast cancer treatment Herceptin and forced to take her local NHS trust to court? ... Canadian Lung Cancer Study Lauded As Major Advance in Cancer Fight Jan 2, 2006 MedIndia, Prominent among them is the finding that Herceptin is effective in preventing the recurrence of HER-2-positive early-stage breast cancer. ... Odyssey Magazine Features Bullet-tracking Technology Jan 5, 2006 UK News, Odyssey also features the results of a massive, five-year breast-cancer trial, focused on a drug called Herceptin, which UK’s Dr. Edward Romond calls “the ... Breast cancer drug looks promising after more study Dec 13, 2005 Lincoln Journal Star, SAN ANTONIO — The drug Herceptin, already viewed as promising for women with both early and late-stage breast cancer, got another boost Thursday with new ... Aerial boost for Raewyn Dec 22, 2005 Wairarapa Times Age, All the proceeds, amounting to over $700,went to Mrs Keen's cancer fund so she could pay for the cancer drug Herceptin to give her a greater chance of survival ... Targeted cancer therapies: Another step forward Dec 22, 2005 News-Medical.net, ...of the current targeted therapies market will be driven mainly by five key products: Genentech/Roches Rituxan (rituximab), Herceptin (trastuzumab), Avastin ... Breast cancer therapeutics benefits from cytotoxic alternatives Dec 23, 2005 In-PharmaTechnologist.com, Currently Herceptin, a humanised antibody approved in ErbB2 positive breast cancers is the only product that is approved by the Food and Drug Administration ... Woman wins right to fight for new breast cancer drug Dec 21, 2005 Telegraph.co.uk, The drug, Herceptin, is only licensed for women who are "HER2 positive", and whose disease has advanced and spread to other organs. ... FDA approves cancer drugs Dec 31, 2005 North Platte Telegraph, ...breast cancer. Earlier this year, the FDA approved the drug Herceptin for use in treating early stage breast cancer. Puray said ... Targeted cancer therapies: another step forward Dec 23, 2005 Pharmaceutical Business Review ...targeted therapies market is expected to be driven mainly by five key products: Genentech/Roche’s Rituxan (rituximab), Herceptin (trastuzumab), Avastin ... In 2005, Advances Made in Breast Cancer Treatment and Detection Dec 28, 2005 Newswise (press release) In two large clinical trials, trastuzumab (Herceptin), which has been available for women with advanced breast cancer, was found to help women with early-stage ... Woman wins ruling over breast cancer drug Dec 21, 2005 Independent, A mother-of-three has won the right to mount a legal challenge to her local NHS trust's refusal to give her the breast cancer drug Herceptin. ... Cancer victim wins hearing over drug Dec 21, 2005 Financial Times, A former restaurant manager has won the right to bring a legal challenge to her National Health Service trust's refusal to provide Herceptin, the breast cancer ... Patient says she was denied drug funding Dec 21, 2005 United Press International 21 (UPI) -- A British high court will review the case of a woman with breast cancer who claims a hospital refused to pay for the drug Herceptin. ... Another British Woman In Court For New Breast Cancer Drug Dec 22, 2005 MedIndia, Anne Marie Rogers has won the right to fight for receiving the new breast cancer drug, Herceptin. Ms Rogers has been diagnosed with ... Year saw strides against breast cancer Dec 30, 2005 United Press International Specifically, in two large clinical trials, trastuzumab (Herceptin), used to treat women with advanced breast cancer, was found to help women with early-stage ... Life-saving treatment to continue Dec 20, 2005 News Shopper, ...treatment from home. Last week News Shopper reported how red tape meant Janine McDonald was denied Herceptin free on the NHS. But now ... DRUG WIN FOR MUM Dec 21, 2005 Mirror.co.uk, A MUM who went into debt to pay for her breast cancer treatment won the first step yesterday in her battle to get Herceptin prescribed on the NHS. ... US Stock-Index Futures Advance; Apple, Broadcom Shares Rise Jan 11, 2006 Bloomberg ...in New York. Genentech is counting on Avastin and the Herceptin breast- cancer treatment to help the company pass Amgen Inc. as ... UK Conservative Party Reverses Health-Care Policy (Update1) Jan 4, 2006 Bloomberg ...``Costs in the health service will continue to go up,'' he said, adding that the rationing of drugs such as Herceptin could no longer continue. ... Roche bucks softer sector ahead of Genentech Q4 Jan 10, 2006 Reuters ..."The focus of attention will once again be on the extent of off-label use with Avastin in lung cancer and of Herceptin in (HER2+) adjuvant breast cancer," LODH ... Eye On Stocks For Tuesday, Jan. 10 Jan 9, 2006 Forbes UBS Investment Research said it expects the company to report another strong quarter tomorrow, driven by positive growth from Avastin, Herceptin and Rituxan. ... Cell Stress Protein Linked To Aggressive Breast Cancer Jan 9, 2006 Science Daily (press release) ..."Currently, we don't have any targeted treatments like tamoxifen or Herceptin for the aggressive type of breast tumors that express alphaB-crystallin. ... Nation/world briefs Jan 10, 2006 Arizona Republic, ...record. • Genentech Inc. said quarterly profits jumped as more doctors prescribed the cancer drugs, Avastin and Herceptin. Fourth ... Genentech's Shares Fall On Disappointing Avastin Sales Jan 11, 2006 BioWorld Online (subscription), Genentech's breast cancer drug, Herceptin (trastuzumab) posted fourth-quarter sales of $250.1 million, up 98 percent from fourth-quarter 2004 sales of $126 ... |
|
Home Copyright phasechange.org 2006. All Rights Reserved. |